(Q44890455)

7 December 2017

Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. (English)

1 reference

7 December 2017

0 references

poliovirus

1 reference

1

1 reference

7 December 2017

12

Deenan Pillay

1 reference

7 December 2017

Glynis Dunn

2

1 reference

7 December 2017

Aarnoud P Huissoon

3

1 reference

7 December 2017

Dinakantha S Kumararatne

4

1 reference

7 December 2017

Javier Martin

5

1 reference

7 December 2017

Paula O'Leary

6

1 reference

7 December 2017

Ronald A Thompson

7

1 reference

7 December 2017

Husam Osman

8

1 reference

7 December 2017

Philip Wood

9

1 reference

7 December 2017

Philip Minor

10

1 reference

7 December 2017

David J Wood

11

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

7 December 2017

1 reference

7 December 2017

363

1 reference

7 December 2017

9420

1 reference

7 December 2017

1509-1513

1 reference

Paralytic poliomyelitis in a child with agammaglobulinemia

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

The biologic principles of poliovirus eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Vaccine-associated poliomyelitis in the United States, 1961-1972

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Persistent and Fatal Central-Nervous-System ECHOvirus Infections in Patients with Agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Poliomyelitis in hypogammaglobulinemics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

The primary immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Inhibition of poliovirus uncoating by disoxaril (WIN 51711).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

"Endgame" Issues for the Global Polio Eradication Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Inadequacy of mucosal IgM antibodies in selective IgA deficiency: excretion of attenuated polio viruses is prolonged

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Immunological protection of the neonatal gastrointestinal tract: the importance of breast feeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Immunoglobulin A subclasses in infants' saliva and in saliva and milk from their mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Treatment of potentially life-threatening enterovirus infections with pleconaril

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Chronic enteroviral meningo-encephalitis in X-linked agammaglobulinaemia: favourable response to anti-enteroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

Successful treatment of enterovirus infection with the use of pleconaril in 2 infants with severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916150-3

7 January 2021

10.1016/S0140-6736(04)16150-3

Identifiers

DOI

1 reference

7 December 2017

1 reference